A B S T R A C T Gangliosides, glycosphingolipids which contain sialic acid, were studied in human platelets. They represented 0.5% of the platelet lipids and accounted for 6% of the total neuraminic acid content of platelets. Three major ganglioside fractions were identified and characterized. Ganglioside I was hematoside (G6) and comprised 92% of the platelet gangliosides. It contained glucose, galactose, and sialic acid in molar ratios of 1: 1: 1 and no hexosamnine. The imiajor fatty acid was behenate (22: 0). Ganglioside I w-as also identified in isolated platelet granules and membranes. Ganglioside II (5%) contained glucose, galactose. sialic acid, and hexosamines (molar ratios 1: 2: 1: 1). The hexosamines were glucosamine (72%) and galactosamine (28%). It was therefore designated as ganglioside lacto-N-neotetraose. Ganglioside III (2%) contained disialosyllactosyl ceramide (G3A) as well as two other gangliosides which could not be precisely characterized. Gangliosides I, II, and III were susceptible to the action of Clostridiuin perfringens neuraminidase as evidenced by full recovery of sialic acid in its free form after incubation. Neutral platelet glycolipids were qualitatively examined by thinlayer chromatography. The major component was lactosvI ceramide.
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Interactions of gangliosides I and III and serotonin-'4C
were examined in an equilibrium dialysis system at 4°C. The gangliosides bound serotonin-'4C in relatively small quantities, wlhereas cointrol lipids w-ere negative. The binding was essentially tinchainged by reverse dialysis, ultracentrifugation anld stubsequen-t tlhin-laver chromatography. The results are comparable to the previously observed nonmetabolic interactions between wlhole platelets and serotonin in the cold. It is suggested that the orientation and specific distribtution of platelet membrane glycolipids may be important determinants of the unique surface properties of platelets.
INTRODUCTION Gangliosides are glycosphingolipids which by definition
contain one or more residues of acv1lated neuraminic acidl per molecule. Additional components are a sphingosine base, fatty acids, hexoses, and, often, hexosamines.
Gangliosides wvere first discovered in brain and have now been identified in many extraneural tissues (1, 2) . The function of gangliosides is unkno-wn. altlhough several ilnteresting physiological roles have beeni posttulated (3) . Among these are the binding of 5-hydroxytryptamine (5-HT, serotonin)l and univalent cations suclh as Na ' and K+, as well as divalent cations such as Ca".
Calcium plays an important but as vet incompletely(defined role in platelet function and, as in other tissues (4) , may be involved in platelet adenosine 3'15'-monophosphate (cyclic AMIP) metabolism. In additioin, the unique avidity of platelets for serotonin remains unexplained. Finally, it is now becoming apparent that the surface characteristics of cell membranes may be in large part determined by glvcolipids and glycoproteins (5, 6) .
The purpose of this study w-as to examine human platelets for the presence of gangliosides. The gangliosides identified were characterized biochemically and their-interactions with serotonin wN-ere examined in an equiilibrium dialysis system.
METHODS
Pr-eparationt of platclcts. A total of 2846 U of platelet conicentrates (1579 g wet weight of platelets) were processedl at periodic intervals. These were (lonior packs, about 12 hr old and maintained under sterile conditions. Approximately 3 U were combined in each of eight 50-ml conical polypropylene centrifuge tubes at one time. The tubes were centrifuged at 5,000 g for 20 min (18°C). The pellets were pooled and washed three times by resuspension in isotonic saline. The washed platelets were stored at -20°C until immediately before lipid extraction, whereupon the tube was smashed with a hammer, releasing the frozen pellet. If red cell contamination was present the area was sliced off the frozen pellet with a scalpel blade. The washing procedure was monitored by phase microscopy. The final platelet preparations did not contain more than one erythrocyte or leukocyte per 50 high power fields. In general the processed platelets contained no contamination with other cells. Platelet membranes and granules were prepared as previously described (7) .
Sialic acid determinations. The total sialic acid content of platelets was determined first. Washed platelets were hydrolyzed in 0.05 N H2SO4 and the hydrolysates assayed by the thiobarbituric acid (TBA) method of Warren (8) and the resorcinol technique devised by Svennerholm (9) . Measurements were carried out directly, as well as after purification oni ion exchange columns prepared with Dowex 50 (H+) and Dowex 1 (acetate form)' (9). The column procedure was performed in order to remove interfering substances such as hexoses. Quantification of lipid-bound sialic acid was dependent on the state of purification of the gangliosides. Relatively pure preparations could be assayed directly by the resorcinol method (10) with spectrophotometric readings at 580 m,.
When crude samples were under study purification was necessary by thin-layer chromatography (TLC) on silica gel G plates prepared with 1% sodium borate solution in place of water (11). This was followed by resorcinol assay directly on the positively identified spots which were scraped off the plate (12, 13) . In order to facilitate identification of spots containing small amounts of ganglioside a modification of the Suzuki (12, 13) procedure suggested by MacMillan and Wherrett (14) was employed. This was especially useful in estimating quantitative recoveries during the course of purification. Alternatively the Svennerholm column procedure (9) could also be used for quantifying the ganglioside content of crude lipid extracts. However, flocculent material which appeared in the lipid hydrolysates interfered with column filtration and made the procedure less convenient. m, with that of an n-acetyl neuraminic acid (NANA) standard.
Preparatioit of platelet lipid extracts. Thawed platelets were extracted in a Waring Blendor3 at low speed in 4-6 ml of cold acetone per g wet weight at 4°C. The mixture was filtered through a sintered glass funnel (medium porosity). Material remaining on the filter wvas reextracted twice in the same manner. The acetone powder was dried, weighed, and extracted twice with chloroform-methanol 1: 1 (20 ml/g of powder). This was done for 30-min periods at room temperature with vigorous magnetic stirring. Finally the dried powder was extracted twice with chloroform-methanol 1: 2 (10 ml/g powder) for 30 min in a similar manner. The combined chloroform-methanol extracts were evaporated to dryness in a rotary evaporator, redissolved in a total of 45 ml of chloroform-methanol 2: 1, and transferred to 50-ml conical tubes. The tubes were centrifuged at 600 g for 15 min (10°C) in order to remove any remaining insoluble residue. The clear supernates were transferred to a large glass-stoppered graduated cylinder and made up to a volume of chloroform-methanol 2: 1 corresponding to 35 ml/g of original acetone powder (17) . It was necessary to carry out the partitioning procedure (16) according to the particular ganglioside under study. Since the use of salts in the partitioning mixture resulted in a loss of hematoside into the lower phase, partitioning was thenceforth carried out with deionized doubly distilled water. The lower phases vere washed twice with "pure solvents upper phase" without salt. This maneuver resulted in complete recovery of hematoside, as evidenced by its absence from the lower phase. This was verified by TLC of concentrates derived from the lower phase. Partitioning specifically for more polar gangliosides was carried out with 0.1 M KCI which was also included in the wash. In all instances separation of phases was facilitated by centrifugation, which also served to "compress" the "interfacial fluff" which appeared during the water partitioning procedure.
The upper phases were combined, evaporated to a small volume (1 ml), and 20 ml of methanol was added. Saponification was carried out by adding 1.3 ml of 2 N NaOH (final normality 0.1 N) and incubating at 37°C for 3-4 hr with occasional agitation. This procedure removed glycerol phosphatides which may have entered the upper phase during the partitioning step. It did not, however, remove traces of sphingomyelin, which were subsequently separated by TLC. The saponification mixture was extracted three times with 10-ml portions of hexane which removed methyl esters of phospholipid fatty acids. The upper hexane layer was discarded and the lower layer evaporated to 2 ml and transferred to dialysis bags in an additional 6 ml of water. The dialysis bags had previously been boiled in three changes of distilled water. Dialysis was carried out against 6 liters of water (4°C) for at least 48 hr, during which time three changes were made. Finally the dialyzed material was lyophilized and stored at -20°C.
Thin-layer chromatography. The basic TLC techniques were those previously described (18) procedure (levised by Ledeen, Salsmani, anid Cabrera (19) w!as used. The solvenit system was chloroform-methaniol-2.5 N ammonium hydroxide (60: 40: 9) . At the completion of the initial run the plate wvas dried under a stream of nitrogen for 45-60 min. After drying, the plate was replaced in a tank containing a freshly prepared mixture of the same solvent. Solvent-containing tanks were preequilibrated for 1 hr and plates were activated at 110°C for 60 min followed by cooling in a desiccator for 20 min before use. When TLC plates were coated with silica gel G, the separations were adequate but recoveries after elution wvere quantitatively low.
At the completion of a chromatographic run the plates were dried under a stream of nitrogeni. In preparative procedures the plates wvere sprayed with a soluitioln of bromthymol blue in ammoniia (20) . The idenitifie(d gangliosi(le banids were scrape(d fromIl the plate and(I extracte(I tilree timiles with acetone, which removed most of the staini (20) . Elution was thlen carried out usinig 5-10 nml of chlor-oformii-nmethaniolwater, 50: 50: 15 (freshly prel)ared) (19) , anid this was repeated twice. The combined eluates were taken to dryness and stored in the solicl state at -20°C before the next experimental procedure.
Platelet gangliosides were further identified by TIC using two additional solvent systems. Plates precoated with silica gel G were developed with either n-propanol-water (7: 3) (21) or chloroform-methanol-water (60: 35: 8) (21).
Gas-liquiid chromiatography (GLC).
A Hewlett-Packard model 7620A research chromatograph equipped with a model 3370A integrator was used. The detection system was of the flame ionization type. Circular glass columns, 6 ft in overall length, with an inlternal dliameter of A inch were employed. The carrier gas wvas prepurified nitrogen at an inflow rate of 30 cm3/min.
Carbohydrate analyses by GLC were based on methods developed by Sweeley and Walker (22) and by Ledeen and associates (19) . All preparative operations were carried out under cover of nitrogen. Eluates derived from TLC plates (0.2-0.4 Amoles of ganglioside) were placed in methanolysis tubes ' (23) and 2 ml of freshly prepared 0.5 N "instant methanolic HCl" w,ere added. Hydrolysis was carried out under nitrogen for 23 hr at 800C. After cooling the hydrolysates were extracted three times with 3-nil portions of redistilled hexane. Each extraction mixture was centrifuged for 2 min at room temperature (1600 g) in order to sharply delineate the interface between the hexane and methanol layers. The hexane extracts were stored at -20°C under nitrogen before fatty acid analyses. In order to prevent transformation of methyl galactosides into unidentifiable analogs and tlhus invalidate glucose-galactose ratios, 166.7 mg of silver acetate was added to the extracted hydrolysate as described by Windeler and Feldman (24) . The tubes were evaporated under nitrogen, the sides rinsed wvith 0.5 ml of methanol and redried. Finally the tubes were desiccated over KOH for 15 min in vacuo. Reacetylation of sialic acid and any hexosamine which was present was carried out as follows: A mixture of methanol-acetic anhydride (3: 1) was added to the hydrolysates in 0.5-ml amounts and the vortexed mixtures allowed to react under nitrogen for 24 hr in the dark (22) . An additional 1 ml of methanol was added and the silver salts removed by filtration through sintered 'Hewlett-Packard Co., Palo Alto, Calif. 8 Coleman-Delmar Glass Products Div., Perkin-Elmer Corp., Maywood, Ill. glass of ultra-fine porosity. The filtrates were tranlsferre(d to 15-ml conical tubes with teflon-lined screw caps and evaporated to dryness. The sides of the tubes were xvashe(l in order to concentrate the material into the cone of the tube. After desiccation, trimethylsilyl (TM S) derivatives were prepared using 100-200 ,ul of the reagent described by Carter and Gaver (25) . The silvl reagents were evaporated and( the derivatixes taken up in liexane (19) to a finial volume of 25 ul. GLC wxas carried out ioimiiicdiatelv after silylation on a Supelcoport0 column (80/100 mesh) coated x-ith 3%c OV-1.9 The column was previously conditioned for 24-36 hr at 260°C under a nitrogen pressure of 50 psi.
Initial operating conditions were as follows: injection port 230°C; columnl 1600C; detector 3000C. Flow rates through the detector were: hydlrogeni 30 cni3/min; air 450 cim3/mill. prepoldleralice of short-chain fatty acids the initial teniperature was reduced to 145°C. Linearity of detector respoiise to mass, and peak identification were verified as previously described (26, 18) . Wheii indicated, GLC was also carried out on a nonpolar column (Apiezon L) ." This was done to confirm the ideintity of questionable peaks (26) . The hexane layers which were derived froni the original methanolic hydrolysate were taken to dryness and concentrated to a volume of 20 Al. 2-to 4-,ul amounts conitaining the equivaleiit of 0.04 ,iuoles of ganglioside were then subjected to GLC. As in the carbohydrate analyses, blank control samples wvere carried through the entire procedure for reasons comparable to those already mentionled. The necessity for blank controls has been cited by other laboratories (27 fications. The glucose oxidase method18 was employed (15) after hydrolysis of the sample with 2 N HCl (32) (3 hr at 100°C) and neutralization with NaOH (33). The lower phases from the ganglioside extractions were examined for the presence of neutral glycolipids utilizing the techniques of Vance and Sweeley (34) . All solvents were redistilled before use.
RESULTS
Quantification of sialic acid. Since the ganglioside samples were reacetylated after hydrolysis, it was not possible to determine by GLC whether N-glycolylneuraminic acid was present. However, none was detectable in samples kindly analyzed for us by Dr. Robert Ledeen (19) . This confirms the findings of Madoff, Ebbe, and Baldini (35) . The AN-acetyl neuraminic acid (NANA) content of whole platelets was 7.8±0.7 ,g/mg platelet protein, as determined by the resorcinol method (corrected at 450 *no for hexoses) (9) . A comparison of our results as obtained by several different techniques is shown in Table I . Samples analyzed from platelet concentrates derived from bank blood usually gave slightly higher values than those from individual donors.
The quantity of lipid-bound neuraminic acid (which by definition is ganglioside) was then related to the total platelet NANA. This amounted to 6%. In four separate experiments the ganglioside content was also related to total platelet lipid as obtained by a factor derived from lipid phosphorus values (18) . Thus, gangliosides comprise an average of 0.5% of platelet lipids by weight (36) .
Identification of platelet gangliosides. Qualitative analyses were initially carried out in the chloroformmethanol-ammonium hydroxide solvent system (19) . The was also present in a molar ratio of 1.07 to glucose and this was confirmed by colorimetric analysis. Hexosamines were undetectable in ganglioside I. The major longchain base was identified as sphingosine. A typical gasliquid chromatograph of these findings in ganglioside I is shown in Fig. 2 . The results confirm the identity of the predominant platelet ganglioside as hematoside.
There was a preponderance of long-chain fatty acids in ganglioside I. The major component was behenate (22: 0), which comprised 33.6% of the total. This was followed by nervonate (24: 1), 18.7%, and lignocerate (24: 0), 14.8%. Hematoside fatty acid methyl esters were also examined for the presence of hydroxy fatty acids (27) , but none were found by TLC.
The carbohydrate composition of ganglioside II most closely resembled ganglioside GLNnT1 (NANA) (lacto-N-neotetraose) (38, 41) . The components present and their molar ratios with respect to glucose were: galactose (1.88), NANA (0.88), long-chain base (0.92), hexosamines (0.94). The major hexosamine was glucosamine (72%). Galactosamine (28%) was also present.
In contrast to hematoside, ganglioside II was characterized by the presence of palmitic acid (31.2%). However, the long-chain fatty acid pattern was somewhat similar-behenate (17.0%), lignocerate (9.2%), and nervonate (20.0%).
GLC analyses of ganglioside III were not compatible with integral ratios of the carbohydrate components. Rather, the ratios suggested the presence of a mixture of gangliosides. This prompted reinvestigation of the fraction by two other TLC systems which indeed demonstrated three components. Nevertheless, the carbohydrate ratios obtained indicated the presence of multiple sialic acid units. The hexosamines present were glucosamine (73%) and galactosamine (27%). Palmitate (16: 0) predominated in the ganglioside III mixture (54.5%). Most notable otherwise was the presence of relatively short-chain fatty acids as compared to gangliosides I and II.
The results of GLC analyses of the carbohydrates and fatty acids in gangliosides I, II, and III are summarized in Tables II and III . As in hematoside, the major longchain base in gangliosides II and III was sphingosine.
Neuraminidase reaction with platelet gangliosides. Assays of free sialic acid after neuraminidase treatment indicated that gangliosides I, II, and III were susceptible to the action of the enzyme. In all instances free NANA recoveries were close to 100%. The reaction product obtained from hematoside was lactosyl ceramide, which further confirmed its identity. The results of this experi-,ment are depicted in Fig. 3 . Experiments with gangliosides II and III were more difficult to evaluate and had to be interpreted in conjunction with the GLC and TLC data. The product of ganglioside II showed no definite resorcinol staining spots other than free NANA, which was in agreement with the TBA assay. The one major cleavage product was an orcinol positive spot on TLC. This component was presumed to be a ceramide tetrahexoside although it did not cochromatograph with a standard marker. The standard (galactosyl-N-acetylgalactosaminyllactosyl ceramide) was prepared in our laboratory from bovine brain gangliosides and did not contain glucosamine. Since glucosamine is present in ganglioside II it may have influenced the chromatographic mobility of the neuraminidase product. However, subsequent GLC analysis verified its identity as a ceramide tetrahexoside.
In the case of ganglioside III, lactosyl ceramide was a major cleavage product as found by TLC Experiments were subsequently carried out in an attempt to modify and/or reverse the binding interactions which took place. In order to remove most of the free serotonin, the dialysis system was reversed by repeatedly replacing the contents of the chamber opposite that containing the test material with fresh buffer and allowing the system to equilibrate. This was done until the counts in this chamber were reduced to less than 250 cpm/25 Al portion. There was little or no reduction in the counts that had been originally bound to the lipid samples. In the case of a control, such as lysolecithin, the relatively insigniificant amounts of serotonin slhich did bind could be virtually removed by reverse dialysis. Addition of calciumll or reserpine to the dialysis system had no effect on the results, and when EDTA was used it directly bound 5-HT in the control samples. Inclusion of an energy source suclh as ATP was not possible since this nucleotide directly complexes with serotonin (42) . Furthermore, several of the lipids evaluated for serotonin binding were converted to their acid form by treatment with Dowex 50 (H+ form), but the 5-HT interactions were not altered.
At the conclusion of several dialysis exeriments samples of human platelet ganglioside III, ganglioside I, bovine brain Gm,, and serotonin-'4C controls were subjected to ultracentrifugation (see 'Methods). The extent of binding before ultracentrifugation was determined by the final differenice in counts between the two sides of the cell. In all instances except the serotonin control the higlhest concentration of bound radioactivity sedimented to the bottom of the ultracentrifuge tube, and this was positively correlated with assays for sialic acid content. The results were particularly striking in the case of platelet gangliosides III and I and are summarized in Table V .
The sedimented ganglioside III from the ultracentrifuge experiments was then subjected to TLC along with cold 5-HT and serotonin-"C controls (as described in TMethods). It was found that 77% of the bound radioac- tivity remained at the origin of the plate in the lipid spot, and the serotonin controls had migrated to the vicinity of the solvent front. It was thus concluded that the radioactivity originally bound by the ganglioside in the dialysis chamber had persisted throughout the ultracentrifugation and TLC procedures.
DISCUSSION
The sialic acid content of whole platelets is 7.8±0.7 Ag/ mg platelet protein. This is less than the figure of 15.5 lAg reported by Madoff and associates (35) . Since precise quantification of sialic acid was important for the ganglioside studies, techniques for measuring NANA and factors influencing the results were investigated in detail. As shown in Table I , the values obtained by several methods for NANA measurement were consistent. As an additional control, several units of platelets were processed as described by Madoff and coworkers (35) , but this had no effect on the results. 6% of the total platelet neuraminic acid was lipid-bound. This figure is comparable to those obtained by Puro, Maury, and Huttunen (2-8%) in a survey of the ganglioside content of eight extraneural tissues of the rat, rabbit, and pig (2) . It is in marked contrast to brain tissue, where more than 50% of the NANA is lipid-bound (2).
Ganglioside I (hematoside) comprised 92% of the total platelet gangliosides. Its identification was confirmed by TLC, GLC, and neuraminidase studies. Hematoside is the major extraneural ganglioside (19) and its presence in a wide variety of tissues has been reported (43) . For example, 92% of bovine adrenal medulla gangliosides are hematosides (19) . In fact, the term "hematoside" was first coined by Yamakawa and Suzuki when they isolated this glycosphingolipid from equine erythrocytes (44) . Our finding of hematoside as the major platelet ganglioside (45) has recently been confirmed by Tao, Jamieson, and Sweeley (46) . The fatty acid composition of ganglioside I was comparable to that of other extraneural hematosides (27) . Long-chain fatty acids such as behenate (33.6%) predominated.
Ganglioside II, which represented 5% of platelet gangliosides, is a relatively novel glycosphingolipid. It was first described in bovine erythrocytes and spleen (38) , and nmore recently Dawson (47) has identified a ganglioside with similar components in human erythrocytes.
Furthermore, Etzrodt (30) found ganglioside lacto-N7-neotetraose in bovine platelets. Relatively large amounts of ganglioside II were required for its chemical identification, and insufficient quantities remained for use in the serotonin binding studies. In contrast to ganglioside I. large amounts of palmitic acid were found in ganglioside II.
Ganglioside III (2% of platelet gangliosides) was initiallv identified as G3A. Although the neuraminidase stud- (46) .
Several previous lines of investigation indicated that a study of platelet gangliosides with particular reference to a possible interaction with serotonin would be of great interest. Platelets can take up 5-HT by an active transport mechanism at 37°C and by passive diffusion and adsorption at 2°C (49). Baumgartner and Born (50) have proposed that serotonin is bound to a specific receptor on the outer surface of the platelet membrane. The receptor is part of a "carrier system" that functions to move 5-HT to the inner portion of the membrane. Serotonin is then either metabolized in the platelet cytoplasm or taken up by specific storage organelles. The precise nature of the 5-HT receptor has been a subject of interest for several years. Woolley and Gommni (51) (52) demonstrated that gangliosides in aqueous media could bind 5-HT as well as other pharmacologic agents such as lysergic acid diethylamide and chlorpromazine. Gielen Human Platelet Gangliosides (53, 54) (35) reported that 74% of the total sialic acid of frozen and thawed platelets was liberated by neuraminidase. Barber Addendumn. Since our manuscript was submitted for publication another paper has come to our attention (62) in which the presence of hematoside was reported in human platelets.
